Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2013

Open Access 01-12-2013 | Original investigation

Role of ROCK upregulation in endothelial and smooth muscle vascular functions in diabetic rat aorta

Authors: Figen Amber Cicek, Hilmi B Kandilci, Belma Turan

Published in: Cardiovascular Diabetology | Issue 1/2013

Login to get access

Background

The RhoA/ROCK signaling pathway mediates vascular smooth muscle contraction while endogenous NO induces vasodilation through its inhibition. Since myosin light chain phosphatase (MLCP) and eNOS are targeted by RhoA/ROCK upregulation then turn to lead abnormalities in vasculature, we aimed to examine whether less endothelial NO-production and inhibited eNOS together with an upregulation of RhoA/ROCK signaling pathway in thoracic aorta can play an important role in vascular dysfunction under hyperglycemia.

Methods

We used streptozotocin-injected rats, as a model of type 1 diabetes, and their lean controls to investigate the role of ROCK upregulation in the function of toracic aorta by using electrophysiological and biochemical techniques.

Results

The protein level of ROCK isoform ROCK2 was found to be 2.5-fold higher in endothelium-intact aortic rings of the diabetic rats compared to those of the controls while its level in endothelium-denuded rings was similar among these two groups. Phosphorylation level of eNOS in endothelium-intact rings from the diabetics was 50% less compared to that of the control. ROCK inhibitors, either Y27632 or HA1077, induced concentration-dependent relaxation with a marked left-shift in phenylephrine pre-contracted endothelium-intact rings from either diabetics or high glucose incubated controls while pretreatment of these rings with L-NAME abolished this shift, fully. Moreover, phosphorylation levels of both MLCP and MLC in endothelium-denuded rings were markedly higher in the diabetics than the controls.

Conclusion

We demonstrated that diabetes-induced vascular dysfunction can arise due to either inbition of eNOS, thereby less endothelial NO-production, either directly or indirectly, in part, due to an upregulation of ROCK2 by hyperglycemia. Additionally, our data demonstrate that high phosphorylation levels of both MLC and MLCP in endothelium-denuded rings can be due to a less endothelial NO-production dependent ROCK upregulation in the smooth muscle cells under hyperglycemia, as well.
Appendix
Available only for authorised users
Literature
1.
go back to reference Akalin SBK, Ceriello A, Das AK, Kilpatrick ES, Koblik T, Munichoodappa CS, Pan CY, Rosenthall W, Shestakova M, Wolnik B, Woo V, Yang WY, Yilmaz MT: Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control. Int J Clin Pract. 2009, 63 (10): 1421-5. 10.1111/j.1742-1241.2009.02165.x.CrossRefPubMed Akalin SBK, Ceriello A, Das AK, Kilpatrick ES, Koblik T, Munichoodappa CS, Pan CY, Rosenthall W, Shestakova M, Wolnik B, Woo V, Yang WY, Yilmaz MT: Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control. Int J Clin Pract. 2009, 63 (10): 1421-5. 10.1111/j.1742-1241.2009.02165.x.CrossRefPubMed
2.
go back to reference Kannel WBMD: Diabetes and cardiovascular risk factors: the Framingham study. Circulation. 1979, 59 (1): 8-13. 10.1161/01.CIR.59.1.8.CrossRefPubMed Kannel WBMD: Diabetes and cardiovascular risk factors: the Framingham study. Circulation. 1979, 59 (1): 8-13. 10.1161/01.CIR.59.1.8.CrossRefPubMed
3.
go back to reference Kalani M: The importance of endothelin-1 for microvascular dysfunction in diabetes. Vasc Health Risk Manag. 2008, 4 (5): 1061-1068.PubMedCentralPubMed Kalani M: The importance of endothelin-1 for microvascular dysfunction in diabetes. Vasc Health Risk Manag. 2008, 4 (5): 1061-1068.PubMedCentralPubMed
4.
go back to reference Khan MATC, Calvert RC, Mikhailidis DP, Morgan RJ: Decreased urinary bladder apoptosis in a rabbit model of diabetes mellitus. Urol Res. 2002, 30 (1): 79-83. 10.1007/s00240-002-0233-x.CrossRefPubMed Khan MATC, Calvert RC, Mikhailidis DP, Morgan RJ: Decreased urinary bladder apoptosis in a rabbit model of diabetes mellitus. Urol Res. 2002, 30 (1): 79-83. 10.1007/s00240-002-0233-x.CrossRefPubMed
5.
go back to reference Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S: Endothelial dysfunction as a target for prevention of cardiovascular disease. Diabetes Care. 2009, 32 (Suppl 2): S314-321.PubMedCentralCrossRefPubMed Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S: Endothelial dysfunction as a target for prevention of cardiovascular disease. Diabetes Care. 2009, 32 (Suppl 2): S314-321.PubMedCentralCrossRefPubMed
6.
go back to reference Fitzgerald SM, Kemp-Harper BK, Tare M, Parkington HC: Role of endothelium-derived hyperpolarizing factor in endothelial dysfunction during diabetes. Clin Exp Pharmacol Physiol. 2005, 32 (5–6): 482-487.CrossRefPubMed Fitzgerald SM, Kemp-Harper BK, Tare M, Parkington HC: Role of endothelium-derived hyperpolarizing factor in endothelial dysfunction during diabetes. Clin Exp Pharmacol Physiol. 2005, 32 (5–6): 482-487.CrossRefPubMed
7.
go back to reference Bolz SS, Vogel L, Sollinger D, Derwand R, de Wit C, Loirand G, Pohl U: Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway. Circulation. 2003, 107 (24): 3081-3087. 10.1161/01.CIR.0000074202.19612.8C.CrossRefPubMed Bolz SS, Vogel L, Sollinger D, Derwand R, de Wit C, Loirand G, Pohl U: Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway. Circulation. 2003, 107 (24): 3081-3087. 10.1161/01.CIR.0000074202.19612.8C.CrossRefPubMed
8.
go back to reference El-Remessy AB, Tawfik HE, Matragoon S, Pillai B, Caldwell RB, Caldwell RW: Peroxynitrite mediates diabetes-induced endothelial dysfunction: possible role of Rho kinase activation. Exp Diabetes Res. 2010, 2010: 247861.PubMedCentralCrossRefPubMed El-Remessy AB, Tawfik HE, Matragoon S, Pillai B, Caldwell RB, Caldwell RW: Peroxynitrite mediates diabetes-induced endothelial dysfunction: possible role of Rho kinase activation. Exp Diabetes Res. 2010, 2010: 247861.PubMedCentralCrossRefPubMed
9.
go back to reference Kizub IV, Pavlova OO, Johnson CD, Soloviev AI, Zholos AV: Rho kinase and protein kinase C involvement in vascular smooth muscle myofilament calcium sensitization in arteries from diabetic rats. Br J Pharmacol. 2010, 159 (8): 1724-1731. 10.1111/j.1476-5381.2010.00666.x.PubMedCentralCrossRefPubMed Kizub IV, Pavlova OO, Johnson CD, Soloviev AI, Zholos AV: Rho kinase and protein kinase C involvement in vascular smooth muscle myofilament calcium sensitization in arteries from diabetic rats. Br J Pharmacol. 2010, 159 (8): 1724-1731. 10.1111/j.1476-5381.2010.00666.x.PubMedCentralCrossRefPubMed
10.
go back to reference Yao L, Chandra S, Toque HA, Bhatta A, Rojas M, Caldwell RB, Caldwell RW: Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout. Cardiovasc Res. 2013, 97 (3): 509-519. 10.1093/cvr/cvs371.PubMedCentralCrossRefPubMed Yao L, Chandra S, Toque HA, Bhatta A, Rojas M, Caldwell RB, Caldwell RW: Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout. Cardiovasc Res. 2013, 97 (3): 509-519. 10.1093/cvr/cvs371.PubMedCentralCrossRefPubMed
11.
go back to reference Hirano K: Current topics in the regulatory mechanism underlying the Ca2+ sensitization of the contractile apparatus in vascular smooth muscle. J Pharmacol Sci. 2007, 104 (2): 109-115. 10.1254/jphs.CP0070027.CrossRefPubMed Hirano K: Current topics in the regulatory mechanism underlying the Ca2+ sensitization of the contractile apparatus in vascular smooth muscle. J Pharmacol Sci. 2007, 104 (2): 109-115. 10.1254/jphs.CP0070027.CrossRefPubMed
12.
go back to reference Somlyo AP, Somlyo AV: Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev. 2003, 83 (4): 1325-1358.CrossRefPubMed Somlyo AP, Somlyo AV: Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev. 2003, 83 (4): 1325-1358.CrossRefPubMed
13.
go back to reference Wang Y, Zheng XR, Riddick N, Bryden M, Baur W, Zhang X, Surks HK: ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells. Circ Res. 2009, 104 (4): 531-540. 10.1161/CIRCRESAHA.108.188524.PubMedCentralCrossRefPubMed Wang Y, Zheng XR, Riddick N, Bryden M, Baur W, Zhang X, Surks HK: ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells. Circ Res. 2009, 104 (4): 531-540. 10.1161/CIRCRESAHA.108.188524.PubMedCentralCrossRefPubMed
14.
go back to reference Zeydanli EN, Bilginoglu A, Tanriverdi E, Gurdal H, Turan B: Selenium restores defective beta-adrenergic receptor response of thoracic aorta in diabetic rats. Mol Cell Biochem. 2010, 338 (1–2): 191-201.CrossRefPubMed Zeydanli EN, Bilginoglu A, Tanriverdi E, Gurdal H, Turan B: Selenium restores defective beta-adrenergic receptor response of thoracic aorta in diabetic rats. Mol Cell Biochem. 2010, 338 (1–2): 191-201.CrossRefPubMed
15.
go back to reference Zeydanli EN, Turan B: Omega-3E treatment regulates matrix metalloproteinases and prevents vascular reactivity alterations in diabetic rat aorta. Can J Physiol Pharmacol. 2009, 87 (12): 1063-1073. 10.1139/Y09-112.CrossRefPubMed Zeydanli EN, Turan B: Omega-3E treatment regulates matrix metalloproteinases and prevents vascular reactivity alterations in diabetic rat aorta. Can J Physiol Pharmacol. 2009, 87 (12): 1063-1073. 10.1139/Y09-112.CrossRefPubMed
16.
go back to reference Kinoshita Y, Saito M, Satoh I, Shomori K, Suzuki H, Yamada M, Kono T, Satoh K: General administration of cyclohexenonic long-chain fatty alcohol ameliorates hyperreactivity of STZ-induced diabetic rat aorta. Life Sci. 2006, 78 (13): 1508-1514. 10.1016/j.lfs.2005.07.043.CrossRefPubMed Kinoshita Y, Saito M, Satoh I, Shomori K, Suzuki H, Yamada M, Kono T, Satoh K: General administration of cyclohexenonic long-chain fatty alcohol ameliorates hyperreactivity of STZ-induced diabetic rat aorta. Life Sci. 2006, 78 (13): 1508-1514. 10.1016/j.lfs.2005.07.043.CrossRefPubMed
17.
go back to reference Salum E, Kampus P, Zilmer M, Eha J, Butlin M, Avolio AP, Podramagi T, Arend A, Aunapuu M, Kals J: Effect of vitamin D on aortic remodeling in streptozotocin-induced diabetes. Cardiovasc Diabetol. 2012, 11: 58-10.1186/1475-2840-11-58.PubMedCentralCrossRefPubMed Salum E, Kampus P, Zilmer M, Eha J, Butlin M, Avolio AP, Podramagi T, Arend A, Aunapuu M, Kals J: Effect of vitamin D on aortic remodeling in streptozotocin-induced diabetes. Cardiovasc Diabetol. 2012, 11: 58-10.1186/1475-2840-11-58.PubMedCentralCrossRefPubMed
18.
go back to reference Zeydanli EN, Kandilci HB, Turan B: Doxycycline ameliorates vascular endothelial and contractile dysfunction in the thoracic aorta of diabetic rats. Cardiovasc Toxicol. 2011, 11 (2): 134-147. 10.1007/s12012-011-9107-1.CrossRefPubMed Zeydanli EN, Kandilci HB, Turan B: Doxycycline ameliorates vascular endothelial and contractile dysfunction in the thoracic aorta of diabetic rats. Cardiovasc Toxicol. 2011, 11 (2): 134-147. 10.1007/s12012-011-9107-1.CrossRefPubMed
19.
go back to reference Kowaluk EA, Seth P, Fung HL: Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle. J Pharmacol Exp Ther. 1992, 262 (3): 916-922.PubMed Kowaluk EA, Seth P, Fung HL: Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle. J Pharmacol Exp Ther. 1992, 262 (3): 916-922.PubMed
20.
go back to reference Shimokawa H: Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. J Cardiovasc Pharmacol. 2002, 39 (3): 319-327. 10.1097/00005344-200203000-00001.CrossRefPubMed Shimokawa H: Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. J Cardiovasc Pharmacol. 2002, 39 (3): 319-327. 10.1097/00005344-200203000-00001.CrossRefPubMed
21.
go back to reference Somlyo AP, Somlyo AV: Signal transduction through the RhoA/Rho-kinase pathway in smooth muscle. J Muscle Res Cell Motil. 2004, 25 (8): 613-615.PubMed Somlyo AP, Somlyo AV: Signal transduction through the RhoA/Rho-kinase pathway in smooth muscle. J Muscle Res Cell Motil. 2004, 25 (8): 613-615.PubMed
22.
go back to reference Kureishi Y, Kobayashi S, Amano M, Kimura K, Kanaide H, Nakano T, Kaibuchi K, Ito M: Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation. J Biol Chem. 1997, 272 (19): 12257-12260. 10.1074/jbc.272.19.12257.CrossRefPubMed Kureishi Y, Kobayashi S, Amano M, Kimura K, Kanaide H, Nakano T, Kaibuchi K, Ito M: Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation. J Biol Chem. 1997, 272 (19): 12257-12260. 10.1074/jbc.272.19.12257.CrossRefPubMed
23.
go back to reference Armentano RL, Levenson J, Barra JG, Fischer EI, Breitbart GJ, Pichel RH, Simon A: Assessment of elastin and collagen contribution to aortic elasticity in conscious dogs. Am J Physiol. 1991, 260 (6 Pt 2): H1870-1877.PubMed Armentano RL, Levenson J, Barra JG, Fischer EI, Breitbart GJ, Pichel RH, Simon A: Assessment of elastin and collagen contribution to aortic elasticity in conscious dogs. Am J Physiol. 1991, 260 (6 Pt 2): H1870-1877.PubMed
24.
go back to reference Fiordaliso F, Cuccovillo I, Bianchi R, Bai A, Doni M, Salio M, De Angelis N, Ghezzi P, Latini R, Masson S: Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes. Life Sci. 2006, 79 (2): 121-129. 10.1016/j.lfs.2005.12.036.CrossRefPubMed Fiordaliso F, Cuccovillo I, Bianchi R, Bai A, Doni M, Salio M, De Angelis N, Ghezzi P, Latini R, Masson S: Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes. Life Sci. 2006, 79 (2): 121-129. 10.1016/j.lfs.2005.12.036.CrossRefPubMed
25.
go back to reference Sugimoto M, Nakayama M, Goto TM, Amano M, Komori K, Kaibuchi K: Rho-kinase phosphorylates eNOS at threonine 495 in endothelial cells. Biochem Biophys Res Commun. 2007, 361 (2): 462-467. 10.1016/j.bbrc.2007.07.030.CrossRefPubMed Sugimoto M, Nakayama M, Goto TM, Amano M, Komori K, Kaibuchi K: Rho-kinase phosphorylates eNOS at threonine 495 in endothelial cells. Biochem Biophys Res Commun. 2007, 361 (2): 462-467. 10.1016/j.bbrc.2007.07.030.CrossRefPubMed
26.
go back to reference Wang J, Liu H, Chen B, Li Q, Huang X, Wang L, Guo X, Huang Q: RhoA/ROCK-dependent moesin phosphorylation regulates AGE-induced endothelial cellular response. Cardiovasc Diabetol. 2012, 11: 7-10.1186/1475-2840-11-7.PubMedCentralCrossRefPubMed Wang J, Liu H, Chen B, Li Q, Huang X, Wang L, Guo X, Huang Q: RhoA/ROCK-dependent moesin phosphorylation regulates AGE-induced endothelial cellular response. Cardiovasc Diabetol. 2012, 11: 7-10.1186/1475-2840-11-7.PubMedCentralCrossRefPubMed
27.
go back to reference Yuan SY, Breslin JW, Perrin R, Gaudreault N, Guo M, Kargozaran H, Wu MH: Microvascular permeability in diabetes and insulin resistance. Microcirculation. 2007, 14 (4–5): 363-373.CrossRefPubMed Yuan SY, Breslin JW, Perrin R, Gaudreault N, Guo M, Kargozaran H, Wu MH: Microvascular permeability in diabetes and insulin resistance. Microcirculation. 2007, 14 (4–5): 363-373.CrossRefPubMed
28.
go back to reference Cohen RA, Tesfamariam B, Weisbrod RM, Zitnay KM: Adrenergic denervation in rabbits with diabetes mellitus. Am J Physiol. 1990, 259 (1 Pt 2): H55-61.PubMed Cohen RA, Tesfamariam B, Weisbrod RM, Zitnay KM: Adrenergic denervation in rabbits with diabetes mellitus. Am J Physiol. 1990, 259 (1 Pt 2): H55-61.PubMed
29.
go back to reference Pfaffman MA, Ball CR, Darby A, Hilman R: Insulin reversal of diabetes-induced inhibition of vascular contractility in the rat. Am J Physiol. 1982, 242 (4): H490-495.PubMed Pfaffman MA, Ball CR, Darby A, Hilman R: Insulin reversal of diabetes-induced inhibition of vascular contractility in the rat. Am J Physiol. 1982, 242 (4): H490-495.PubMed
30.
go back to reference Kobayashi T, Kamata K: Effect of insulin treatment on smooth muscle contractility and endothelium-dependent relaxation in rat aortae from established STZ-induced diabetes. Br J Pharmacol. 1999, 127 (4): 835-842. 10.1038/sj.bjp.0702554.PubMedCentralCrossRefPubMed Kobayashi T, Kamata K: Effect of insulin treatment on smooth muscle contractility and endothelium-dependent relaxation in rat aortae from established STZ-induced diabetes. Br J Pharmacol. 1999, 127 (4): 835-842. 10.1038/sj.bjp.0702554.PubMedCentralCrossRefPubMed
31.
go back to reference Oudot A, Behr-Roussel D, Compagnie S, Caisey S, Le Coz O, Gorny D, Alexandre L, Giuliano F: Endothelial dysfunction in insulin-resistant rats is associated with oxidative stress and COX pathway dysregulation. Physiol Res. 2009, 58 (4): 499-509.PubMed Oudot A, Behr-Roussel D, Compagnie S, Caisey S, Le Coz O, Gorny D, Alexandre L, Giuliano F: Endothelial dysfunction in insulin-resistant rats is associated with oxidative stress and COX pathway dysregulation. Physiol Res. 2009, 58 (4): 499-509.PubMed
32.
go back to reference van Nieuw Amerongen GP, Beckers CM, Achekar ID, Zeeman S, Musters RJ, van Hinsbergh VW: Involvement of Rho kinase in endothelial barrier maintenance. Arterioscler Thromb Vasc Biol. 2007, 27 (11): 2332-2339. 10.1161/ATVBAHA.107.152322.CrossRefPubMed van Nieuw Amerongen GP, Beckers CM, Achekar ID, Zeeman S, Musters RJ, van Hinsbergh VW: Involvement of Rho kinase in endothelial barrier maintenance. Arterioscler Thromb Vasc Biol. 2007, 27 (11): 2332-2339. 10.1161/ATVBAHA.107.152322.CrossRefPubMed
33.
go back to reference van Nieuw Amerongen GP, Musters RJ, Eringa EC, Sipkema P, van Hinsbergh VW: Thrombin-induced endothelial barrier disruption in intact microvessels: role of RhoA/Rho kinase-myosin phosphatase axis. Am J Physiol Cell Physiol. 2008, 294 (5): C1234-1241. 10.1152/ajpcell.00551.2007.CrossRefPubMed van Nieuw Amerongen GP, Musters RJ, Eringa EC, Sipkema P, van Hinsbergh VW: Thrombin-induced endothelial barrier disruption in intact microvessels: role of RhoA/Rho kinase-myosin phosphatase axis. Am J Physiol Cell Physiol. 2008, 294 (5): C1234-1241. 10.1152/ajpcell.00551.2007.CrossRefPubMed
34.
go back to reference Laufs U, Liao JK: Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem. 1998, 273 (37): 24266-24271. 10.1074/jbc.273.37.24266.CrossRefPubMed Laufs U, Liao JK: Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem. 1998, 273 (37): 24266-24271. 10.1074/jbc.273.37.24266.CrossRefPubMed
35.
go back to reference Ming XF, Viswambharan H, Barandier C, Ruffieux J, Kaibuchi K, Rusconi S, Yang Z: Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol Cell Biol. 2002, 22 (24): 8467-8477. 10.1128/MCB.22.24.8467-8477.2002.PubMedCentralCrossRefPubMed Ming XF, Viswambharan H, Barandier C, Ruffieux J, Kaibuchi K, Rusconi S, Yang Z: Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol Cell Biol. 2002, 22 (24): 8467-8477. 10.1128/MCB.22.24.8467-8477.2002.PubMedCentralCrossRefPubMed
36.
go back to reference Higashi M, Shimokawa H, Hattori T, Hiroki J, Mukai Y, Morikawa K, Ichiki T, Takahashi S, Takeshita A: Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ Res. 2003, 93 (8): 767-775. 10.1161/01.RES.0000096650.91688.28.CrossRefPubMed Higashi M, Shimokawa H, Hattori T, Hiroki J, Mukai Y, Morikawa K, Ichiki T, Takahashi S, Takeshita A: Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ Res. 2003, 93 (8): 767-775. 10.1161/01.RES.0000096650.91688.28.CrossRefPubMed
37.
go back to reference Arita R, Hata Y, Nakao S, Kita T, Miura M, Kawahara S, Zandi S, Almulki L, Tayyari F, Shimokawa H: Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage. Diabetes. 2009, 58 (1): 215-226. 10.2337/db08-0762.PubMedCentralCrossRefPubMed Arita R, Hata Y, Nakao S, Kita T, Miura M, Kawahara S, Zandi S, Almulki L, Tayyari F, Shimokawa H: Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage. Diabetes. 2009, 58 (1): 215-226. 10.2337/db08-0762.PubMedCentralCrossRefPubMed
38.
go back to reference Nunes KP, Rigsby CS, Webb RC: RhoA/Rho-kinase and vascular diseases: what is the link?. Cell Mol Life Sci. 2010, 67 (22): 3823-3836. 10.1007/s00018-010-0460-1.PubMedCentralCrossRefPubMed Nunes KP, Rigsby CS, Webb RC: RhoA/Rho-kinase and vascular diseases: what is the link?. Cell Mol Life Sci. 2010, 67 (22): 3823-3836. 10.1007/s00018-010-0460-1.PubMedCentralCrossRefPubMed
39.
go back to reference Axelsson J, Rippe A, Rippe B: Acute hyperglycemia induces rapid, reversible increases in glomerular permeability in nondiabetic rats. Am J Physiol Renal Physiol. 2010, 298 (6): F1306-1312. 10.1152/ajprenal.00710.2009.CrossRefPubMed Axelsson J, Rippe A, Rippe B: Acute hyperglycemia induces rapid, reversible increases in glomerular permeability in nondiabetic rats. Am J Physiol Renal Physiol. 2010, 298 (6): F1306-1312. 10.1152/ajprenal.00710.2009.CrossRefPubMed
40.
go back to reference Xie Z, Su W, Guo Z, Pang H, Post SR, Gong MC: Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells. Cardiovasc Res. 2006, 69 (2): 491-501. 10.1016/j.cardiores.2005.11.002.CrossRefPubMed Xie Z, Su W, Guo Z, Pang H, Post SR, Gong MC: Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells. Cardiovasc Res. 2006, 69 (2): 491-501. 10.1016/j.cardiores.2005.11.002.CrossRefPubMed
42.
go back to reference Sward P, Rippe B: Acute and sustained actions of hyperglycaemia on endothelial and glomerular barrier permeability. Acta Physiol (Oxf). 2012, 204 (3): 294-307. 10.1111/j.1748-1716.2011.02343.x.CrossRef Sward P, Rippe B: Acute and sustained actions of hyperglycaemia on endothelial and glomerular barrier permeability. Acta Physiol (Oxf). 2012, 204 (3): 294-307. 10.1111/j.1748-1716.2011.02343.x.CrossRef
43.
go back to reference Cai H, Harrison DG: Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000, 87 (10): 840-844. 10.1161/01.RES.87.10.840.CrossRefPubMed Cai H, Harrison DG: Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000, 87 (10): 840-844. 10.1161/01.RES.87.10.840.CrossRefPubMed
Metadata
Title
Role of ROCK upregulation in endothelial and smooth muscle vascular functions in diabetic rat aorta
Authors
Figen Amber Cicek
Hilmi B Kandilci
Belma Turan
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2013
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-12-51

Other articles of this Issue 1/2013

Cardiovascular Diabetology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.